A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations

Lancet Infect Dis. 2019 Nov;19(11):1161-1162. doi: 10.1016/S1473-3099(19)30545-6.
No abstract available

MeSH terms

  • Drug Resistance, Multiple, Bacterial*
  • Fecal Microbiota Transplantation / adverse effects*
  • Fecal Microbiota Transplantation / methods
  • Fecal Microbiota Transplantation / standards
  • Government Regulation
  • Humans
  • Immunocompromised Host
  • Microbial Sensitivity Tests
  • Patient Safety
  • United States
  • United States Food and Drug Administration